PreveCeutical Medical PRVCF Stock
PreveCeutical Medical Price Chart
PreveCeutical Medical PRVCF Financial and Trading Overview
| PreveCeutical Medical stock price | 0.02 USD |
| Previous Close | 0.02 USD |
| Open | 0.02 USD |
| Bid | 0.01 USD x 45000000 |
| Ask | 0.02 USD x 6000000 |
| Day's Range | 0.02 - 0.02 USD |
| 52 Week Range | 0.0037 - 0.04 USD |
| Volume | 1K USD |
| Avg. Volume | 20.92K USD |
| Market Cap | 8.93M USD |
| Beta (5Y Monthly) | 0.237 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PRVCF Valuation Measures
| Enterprise Value | 16.23M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -7.507 |
Trading Information
PreveCeutical Medical Stock Price History
| Beta (5Y Monthly) | 0.237 |
| 52-Week Change | -35.36% |
| S&P500 52-Week Change | 15.30% |
| 52 Week High | 0.04 USD |
| 52 Week Low | 0.0037 USD |
| 50-Day Moving Average | 0.01 USD |
| 200-Day Moving Average | 0.01 USD |
PRVCF Share Statistics
| Avg. Volume (3 month) | 20.92K USD |
| Avg. Daily Volume (10-Days) | 29.25K USD |
| Shares Outstanding | 638.19M |
| Float | 490.19M |
| Short Ratio | N/A |
| % Held by Insiders | 14.28% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 5:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -145.32% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -2161789 USD |
| Net Income Avi to Common (ttm) | -689278 USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 35.66K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 4.84M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.163 |
| Book Value Per Share (mrq) | -0.00794453 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1601762 USD |
| Levered Free Cash Flow (ttm) | -2586254 USD |
Profile of PreveCeutical Medical
| Country | United States |
| State | BC |
| City | West Vancouver |
| Address | 5428 Marine Drive |
| ZIP | V7W 2R2 |
| Phone | 604 416 7777 |
| Website | https://www.preveceutical.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its research and development of preventive and therapeutic products derived from organic and nature-identical compounds; synthesized Nature Identical; Sol-Gel Nose-to-Brain delivery platform for Parkinson's disease; develops cannabinoid-based nose-to-brain delivery system for the relief of a various ailments, including pain, inflammation, seizures, and neurological disorders; peptide library synthesis, pharmacological evaluation, alongside pharmacokinetic assessment, and determinations in animal models of pain and inflammation; and non-addictive analgesic peptides for pain management. It also involved in licensing, branding, and marketing nutraceutical and wellness products; Sol-Gel platform; and peptide program. PreveCeutical Medical Inc. is headquartered in West Vancouver, Canada.
Q&A For PreveCeutical Medical Stock
What is a current PRVCF stock price?
PreveCeutical Medical PRVCF stock price today per share is 0.02 USD.
How to purchase PreveCeutical Medical stock?
You can buy PRVCF shares on the OTC Markets OTCQB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for PreveCeutical Medical?
The stock symbol or ticker of PreveCeutical Medical is PRVCF.
Which industry does the PreveCeutical Medical company belong to?
The PreveCeutical Medical industry is Biotechnology.
How many shares does PreveCeutical Medical have in circulation?
The max supply of PreveCeutical Medical shares is 638.19M.
What is PreveCeutical Medical Price to Earnings Ratio (PE Ratio)?
PreveCeutical Medical PE Ratio is now.
What was PreveCeutical Medical earnings per share over the trailing 12 months (TTM)?
PreveCeutical Medical EPS is 0 USD over the trailing 12 months.
Which sector does the PreveCeutical Medical company belong to?
The PreveCeutical Medical sector is Healthcare.
